Bionano Genomics (BNGO) on Thursday disclosed a combined public offering of shares and accompanying warrants to raise an expected $9 million in proceeds.
The company will issue up to 2 million shares of common stock, together with Series E and Series F warrants, at an assumed combined price of $4.92 per share and accompanying warrants, according to a regulatory filing.
The company said it intends to use net proceeds from the offering for working capital and general corporate purposes.
Bionano said that the offering will terminate on Oct. 11.
Price: 4.88, Change: -0.04, Percent Change: -0.73
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.